• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亚油酸与 SARS-CoV-2 RdRp 结合并抑制季节性人类冠状病毒 OC43 的复制。

Linoleic acid binds to SARS-CoV-2 RdRp and represses replication of seasonal human coronavirus OC43.

机构信息

Dr. Rath Research Institute, 5941 Optical Ct., San Jose, CA, 95138, USA.

出版信息

Sci Rep. 2022 Nov 9;12(1):19114. doi: 10.1038/s41598-022-23880-9.

DOI:10.1038/s41598-022-23880-9
PMID:36352079
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9645759/
Abstract

Fatty acids belong to a group of compounds already acknowledged for their broad antiviral efficacy. However, little is yet known about their effect on replication of human coronaviruses. To shed light on this subject, we first screened 15 fatty acids, three lipid-soluble vitamins, and cholesterol, on SARS-CoV-2 RdRp, and identified the four fatty acids with the highest RdRp inhibitory potential. Among them, linoleic acid was found to have the greatest interaction with SARS-CoV-2 RdRp, with its direct binding to the cavity formed by the RNA double helix and protein. Linoleic acid forms hydrophobic interactions with multiple residues, and at the same time forms electrostatic interactions including the hydrogen bond with Lys593 and Asp865. In line with these results, a dose-dependent inhibition of HCoV-OC43 replication in vitro was observed, additionally strengthened by data from in vivo study, which also confirmed anti-inflammatory potential of linoleic acid. Based on these results, we concluded that our study provides a new understanding of the antiviral properties of fatty acids against human coronaviruses including the SARS-CoV-2 strain. Particularly, they lays down a new prospect for linoleic acid's RdRp-inhibitory activity, as a candidate for further studies, which are warranted to corroborate the results presented here.

摘要

脂肪酸属于一类已被广泛认可具有广谱抗病毒功效的化合物。然而,人们对其在人类冠状病毒复制过程中的影响知之甚少。为了阐明这一问题,我们首先筛选了 15 种脂肪酸、3 种脂溶性维生素和胆固醇对 SARS-CoV-2 RdRp 的作用,确定了具有最高 RdRp 抑制潜力的 4 种脂肪酸。其中,亚油酸与 SARS-CoV-2 RdRp 的相互作用最大,其直接与 RNA 双链和蛋白质形成的腔结合。亚油酸与多个残基形成疏水相互作用,同时形成静电相互作用,包括与 Lys593 和 Asp865 的氢键。与这些结果一致,我们观察到亚油酸在体外对 HCoV-OC43 的复制具有剂量依赖性抑制作用,体内研究数据进一步加强了这一结果,同时也证实了亚油酸的抗炎潜力。基于这些结果,我们得出结论,我们的研究为脂肪酸对包括 SARS-CoV-2 株在内的人类冠状病毒的抗病毒特性提供了新的认识。特别是,我们为亚油酸的 RdRp 抑制活性奠定了新的前景,作为进一步研究的候选药物,有必要证实这里提出的结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a590/9646853/76aa3b32f24b/41598_2022_23880_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a590/9646853/537c8776ee2b/41598_2022_23880_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a590/9646853/8843e4f912d6/41598_2022_23880_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a590/9646853/43038c3a73fc/41598_2022_23880_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a590/9646853/7d5ffac48e18/41598_2022_23880_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a590/9646853/c0db433ba219/41598_2022_23880_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a590/9646853/76aa3b32f24b/41598_2022_23880_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a590/9646853/537c8776ee2b/41598_2022_23880_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a590/9646853/8843e4f912d6/41598_2022_23880_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a590/9646853/43038c3a73fc/41598_2022_23880_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a590/9646853/7d5ffac48e18/41598_2022_23880_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a590/9646853/c0db433ba219/41598_2022_23880_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a590/9646853/76aa3b32f24b/41598_2022_23880_Fig6_HTML.jpg

相似文献

1
Linoleic acid binds to SARS-CoV-2 RdRp and represses replication of seasonal human coronavirus OC43.亚油酸与 SARS-CoV-2 RdRp 结合并抑制季节性人类冠状病毒 OC43 的复制。
Sci Rep. 2022 Nov 9;12(1):19114. doi: 10.1038/s41598-022-23880-9.
2
2-((1H-indol-3-yl)thio)-N-phenyl-acetamides: SARS-CoV-2 RNA-dependent RNA polymerase inhibitors.2-((1H-吲哚-3-基)硫代)-N-苯基乙酰胺:SARS-CoV-2 依赖 RNA 的 RNA 聚合酶抑制剂。
Antiviral Res. 2021 Dec;196:105209. doi: 10.1016/j.antiviral.2021.105209. Epub 2021 Nov 18.
3
Viral polymerase binding and broad-spectrum antiviral activity of molnupiravir against human seasonal coronaviruses.莫努匹韦对季节性人类冠状病毒的聚合酶结合和广谱抗病毒活性。
Virology. 2021 Dec;564:33-38. doi: 10.1016/j.virol.2021.09.009. Epub 2021 Oct 2.
4
Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2.新型冠状病毒 PAD 抑制剂对人β冠状病毒 HCoV-OC43 和 SARS-CoV-2 的抗病毒活性。
Antiviral Res. 2022 Apr;200:105278. doi: 10.1016/j.antiviral.2022.105278. Epub 2022 Mar 11.
5
The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase.抗 SARS-CoV-2 RNA 依赖的 RNA 聚合酶的潜在化学结构。
J Med Virol. 2020 Jun;92(6):693-697. doi: 10.1002/jmv.25761. Epub 2020 Mar 18.
6
study indicates antimalarials as direct inhibitors of SARS-CoV-2-RNA dependent RNA polymerase.研究表明,抗疟药物是 SARS-CoV-2-RNA 依赖的 RNA 聚合酶的直接抑制剂。
J Biomol Struct Dyn. 2022 Aug;40(12):5588-5605. doi: 10.1080/07391102.2021.1871956. Epub 2021 Jan 21.
7
Repurposing old drugs as antiviral agents for coronaviruses.将老药重新用作冠状病毒的抗病毒药物。
Biomed J. 2020 Aug;43(4):368-374. doi: 10.1016/j.bj.2020.05.003. Epub 2020 May 23.
8
Discovery and optimization of 2-((1H-indol-3-yl)thio)-N-benzyl-acetamides as novel SARS-CoV-2 RdRp inhibitors.发现并优化 2-((1H-吲哚-3-基)硫代)-N-苄基-乙酰胺类化合物作为新型 SARS-CoV-2 RdRp 抑制剂。
Eur J Med Chem. 2021 Nov 5;223:113622. doi: 10.1016/j.ejmech.2021.113622. Epub 2021 Jun 10.
9
Identifying Small-Molecule Inhibitors of SARS-CoV-2 RNA-Dependent RNA Polymerase by Establishing a Fluorometric Assay.通过建立荧光测定法鉴定 SARS-CoV-2 RNA 依赖性 RNA 聚合酶的小分子抑制剂。
Front Immunol. 2022 Apr 7;13:844749. doi: 10.3389/fimmu.2022.844749. eCollection 2022.
10
Revealing the Inhibition Mechanism of RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2 by Remdesivir and Nucleotide Analogues: A Molecular Dynamics Simulation Study.揭示瑞德西韦和核苷酸类似物对 SARS-CoV-2 的 RNA 依赖性 RNA 聚合酶(RdRp)的抑制机制:分子动力学模拟研究。
J Phys Chem B. 2020 Nov 25;124(47):10641-10652. doi: 10.1021/acs.jpcb.0c06747. Epub 2020 Nov 15.

引用本文的文献

1
Traditional Chinese Medicine for Viral Pneumonia Therapy: Pharmacological Basis and Mechanistic Insights.用于治疗病毒性肺炎的中医药:药理基础与作用机制洞察
Int J Biol Sci. 2025 Jan 6;21(3):989-1013. doi: 10.7150/ijbs.105086. eCollection 2025.
2
Valproic acid use is associated with diminished risk of contracting COVID-19, and diminished disease severity: Epidemiologic and in vitro analysis reveal mechanistic insights.丙戊酸的使用与降低 COVID-19 感染风险和降低疾病严重程度有关:流行病学和体外分析揭示了机制见解。
PLoS One. 2024 Aug 2;19(8):e0307154. doi: 10.1371/journal.pone.0307154. eCollection 2024.
3
Establishment of a screening platform based on human coronavirus OC43 for the identification of microbial natural products with antiviral activity.

本文引用的文献

1
Natural products' role against COVID-19.天然产物在抗击新冠病毒中的作用。
RSC Adv. 2020 Jun 19;10(39):23379-23393. doi: 10.1039/d0ra03774e. eCollection 2020 Jun 16.
2
De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report.免疫功能低下患者持续性 SARS-CoV-2 感染治疗过程中雷米昔韦耐药突变的从头出现:一例病例报告。
Nat Commun. 2022 Mar 17;13(1):1547. doi: 10.1038/s41467-022-29104-y.
3
The Molecular Basis of COVID-19 Pathogenesis, Conventional and Nanomedicine Therapy.
建立基于人冠状病毒 OC43 的筛选平台,用于鉴定具有抗病毒活性的微生物天然产物。
Microbiol Spectr. 2024 Jan 11;12(1):e0167923. doi: 10.1128/spectrum.01679-23. Epub 2023 Nov 27.
4
Linoleic acid: a natural feed compound against porcine epidemic diarrhea disease.亚油酸:一种天然饲料化合物,可对抗猪流行性腹泻病。
J Virol. 2023 Dec 21;97(12):e0170023. doi: 10.1128/jvi.01700-23. Epub 2023 Nov 27.
5
Sniffing out safety: canine detection and identification of SARS-CoV-2 infection from armpit sweat.嗅出安全:犬类从腋窝汗液中检测和识别新冠病毒感染
Front Med (Lausanne). 2023 Sep 19;10:1185779. doi: 10.3389/fmed.2023.1185779. eCollection 2023.
6
Phytochemicals and micronutrients in suppressing infectivity caused by SARS-CoV-2 virions and seasonal coronavirus HCoV-229E in vivo.植物化学物质和微量营养素在体内抑制严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒粒子和季节性冠状病毒HCoV-229E引起的感染性方面的作用
Eur J Microbiol Immunol (Bp). 2023 May 31;13(1):6-14. doi: 10.1556/1886.2023.00010. Print 2023 Jul 7.
新型冠状病毒病发病机制的分子基础、常规药物和纳米医学治疗。
Int J Mol Sci. 2021 May 21;22(11):5438. doi: 10.3390/ijms22115438.
4
Reducing SARS-CoV-2 pathological protein activity with small molecules.用小分子降低SARS-CoV-2病理性蛋白活性。
J Pharm Anal. 2021 Aug;11(4):383-397. doi: 10.1016/j.jpha.2021.03.012. Epub 2021 Apr 5.
5
Metabolic programs define dysfunctional immune responses in severe COVID-19 patients.代谢程序定义了重症 COVID-19 患者功能失调的免疫反应。
Cell Rep. 2021 Mar 16;34(11):108863. doi: 10.1016/j.celrep.2021.108863. Epub 2021 Feb 26.
6
Polyunsaturated ω-3 fatty acids inhibit ACE2-controlled SARS-CoV-2 binding and cellular entry.多不饱和 ω-3 脂肪酸抑制 ACE2 控制的 SARS-CoV-2 结合和细胞进入。
Sci Rep. 2021 Mar 4;11(1):5207. doi: 10.1038/s41598-021-84850-1.
7
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A.普里替定通过靶向宿主蛋白 eEF1A 对 SARS-CoV-2 具有强大的临床前疗效。
Science. 2021 Feb 26;371(6532):926-931. doi: 10.1126/science.abf4058. Epub 2021 Jan 25.
8
SARS-CoV-2 Spike Alterations Enhance Pseudoparticle Titers and Replication-Competent VSV-SARS-CoV-2 Virus.SARS-CoV-2 刺突突变增强假病毒滴度和复制型 VSV-SARS-CoV-2 病毒。
Viruses. 2020 Dec 18;12(12):1465. doi: 10.3390/v12121465.
9
Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice.K18 人血管紧张素转化酶 2 转基因小鼠中严重急性呼吸综合征冠状病毒 2 感染的致死性。
Nat Commun. 2020 Nov 30;11(1):6122. doi: 10.1038/s41467-020-19891-7.
10
COVID-19 and myeloid cells: complex interplay correlates with lung severity.新型冠状病毒肺炎与髓系细胞:复杂相互作用与肺部严重程度相关。
J Clin Invest. 2020 Dec 1;130(12):6214-6217. doi: 10.1172/JCI143361.